Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A "bad responder" to statins.

Dirk Devroey1, W Betz, P Coigniez

  • 1Department of General Practice, University of Brussels, Laarbeeklaan 103, B-1090 Brussels, Belgium. dirk.devroey@vub.ac.be

Cardiology
|July 30, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding burnout and engagement during medical residency: a multifactorial and longitudinal approach.

BMC medical education·2026
Same author

Burnout and Engagement Within Medical Education: A Repeated Measures Study on Their Evolution and Main Determinants.

Perspectives on medical education·2026
Same author

Understanding dropout intentions in medical education: The role of burnout, demands, and resources.

Medical education·2025
Same author

Elevated blood eosinophil counts in stable COPD patients in Belgian primary care: prevalence and clinical characteristics.

Acta clinica Belgica·2025
Same author

Burnout in medical education: interventions from a co-creation process.

BMC medical education·2025
Same author

Factors influencing medication adherence among hypertensive patients in primary care settings in Central Vietnam: A cross-sectional study.

PloS one·2025
Same journal

Reply Letter.

Cardiology·2026
Same journal

Aortic Valve Sclerosis: More Than an Incidental Echocardiographic Finding.

Cardiology·2026
Same journal

Can resting segmental strain identify obstructive coronary artery disease in chronic coronary syndrome patients referred to CABG?

Cardiology·2026
Same journal

Mortality Impact of Stroke and Major Bleeding Across the Ejection Fraction Spectrum in Patients Hospitalized for Acute Heart Failure With Prevalent Atrial Fibrillation.

Cardiology·2026
Same journal

Impact of Inflammatory Disorders on Outcomes in Acute Heart Failure: A Nationwide Analysis.

Cardiology·2026
Same journal

Predictors and Clinical Impact of Tricuspid Regurgitation After Pericardiectomy for Constrictive Pericarditis.

Cardiology·2026
See all related articles

Pravastatin worsened cholesterol levels, but fenofibrate dramatically improved high-density lipoprotein cholesterol (HDL-C). Fenofibrate therapy resulted in a twofold increase in HDL-C compared to pravastatin.

Area of Science:

  • Cardiology
  • Pharmacology
  • Metabolic Disorders

Background:

  • Dyslipidemia management often involves statins.
  • Pravastatin is a commonly prescribed statin for lowering cholesterol.
  • Individual responses to lipid-lowering medications can vary significantly.

Observation:

  • A patient experienced a significant worsening of lipid profiles, including high-density lipoprotein cholesterol (HDL-C), total cholesterol to HDL-C ratio, and low-density lipoprotein cholesterol to HDL-C ratio during pravastatin treatment.
  • These adverse lipid changes persisted for three years despite pravastatin therapy.

Findings:

  • Switching from pravastatin to fenofibrate led to a remarkable improvement in lipid parameters.
  • High-density lipoprotein cholesterol (HDL-C) levels at least doubled after initiating fenofibrate compared to the levels observed during pravastatin treatment.

Related Experiment Videos

Implications:

  • Fenofibrate may be a more effective alternative for patients with specific lipid metabolism issues unresponsive or poorly responsive to pravastatin.
  • This case highlights the importance of personalized treatment strategies in managing dyslipidemia.
  • Further research could explore the mechanisms behind differential responses to statins and fibrates in lipid management.